03.19.15
Chief financial officer (CFO) of Spectranetics Corp., Guy Childs, is transitioning from his current role with the medical device company. He will remain CFO until a replacement can be found. Following the transition, he will serve as a vice president with responsibilities including treasury, investor relations and financial planning.
“On behalf of Spectranetics and our shareholders, I want to thank Guy for his outstanding leadership and guidance in his role as chief financial officer, in which he has served since January 2003,” said Presdient and CEO Scott Drake. “I look forward to continuing our partnership as we expand our internal corporate capabilities. Our team, customers and investors will benefit from Guy’s commitment to excellence and driving Spectranetics value in his important strategic role following the transition.”
“I am invigorated to remain with the leadership team in a key role that will leverage my strengths, provide continuity, and enable new, world-class talent to join our team during this exciting time. I have great confidence in Spectranetics’ growth trajectory and look forward to capitalizing on our transformational opportunities,” said Childs.
Spectranetics is based in Colorado Springs, Colo. The company makes single-use medical devices for minimally invasive procedures within the cardiovascular system.
“On behalf of Spectranetics and our shareholders, I want to thank Guy for his outstanding leadership and guidance in his role as chief financial officer, in which he has served since January 2003,” said Presdient and CEO Scott Drake. “I look forward to continuing our partnership as we expand our internal corporate capabilities. Our team, customers and investors will benefit from Guy’s commitment to excellence and driving Spectranetics value in his important strategic role following the transition.”
“I am invigorated to remain with the leadership team in a key role that will leverage my strengths, provide continuity, and enable new, world-class talent to join our team during this exciting time. I have great confidence in Spectranetics’ growth trajectory and look forward to capitalizing on our transformational opportunities,” said Childs.
Spectranetics is based in Colorado Springs, Colo. The company makes single-use medical devices for minimally invasive procedures within the cardiovascular system.